Marc T. Schmalzing

Oberdürrbacher Str. 6
Wuerzburg, BY 97080, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 162 publications

Does the RESIST score predict 5-year mortality beyond EUSTAR? Validation in the German Network for Systemic Sclerosis.

Does the RESIST score predict 5-year mortality beyond EUSTAR? Validation in the German Network for Systemic Sclerosis.

Journal: Annals of the rheumatic diseases
Published: July 08, 2026

Increased optic nerve-region [18F]FDG uptake in clinically isolated polymyalgia rheumatica: an exploratory PET/CT study within the GCA-PMR spectrum.

Increased optic nerve-region [18F]FDG uptake in clinically isolated polymyalgia rheumatica: an exploratory PET/CT study within the GCA-PMR spectrum.

Journal: Frontiers in immunology
Published: April 30, 2026

Title Not Found

Title Not Found

Journal: Zeitschrift fur Rheumatologie
Published: April 27, 2026

CXCR4-targeted PET/CT in early systemic sclerosis-associated interstitial lung disease: a prospective proof-of-concept study of in vivo inflammatory activity.

CXCR4-targeted PET/CT in early systemic sclerosis-associated interstitial lung disease: a prospective proof-of-concept study of in vivo inflammatory activity.

Journal: European journal of nuclear medicine and molecular imaging
Published: April 20, 2026

Update: DMARDs for MGUS

Update: DMARDs for MGUS

Journal: Zeitschrift fur Rheumatologie
Published: April 08, 2026

Real-world treatment patterns and determinants of therapy in systemic sclerosis: findings from the German Network for SSc cohort.

Real-world treatment patterns and determinants of therapy in systemic sclerosis: findings from the German Network for SSc cohort.

Journal: Arthritis research & therapy
Published: March 27, 2026

Association of an app-based intervention with improvements in mobility, trunk muscle strength and patient-reported disease activity in axial spondyloarthritis: a 24-week pre-post study.

Association of an app-based intervention with improvements in mobility, trunk muscle strength and patient-reported disease activity in axial spondyloarthritis: a 24-week pre-post study.

Journal: Therapeutic advances in musculoskeletal disease
Published: March 25, 2026

Proposal of the rheumatology societies in the D-A-CH region for a uniform German nomenclature for Sjögren's disease

Proposal of the rheumatology societies in the D-A-CH region for a uniform German nomenclature for Sjögren's disease

Journal: Zeitschrift fur Rheumatologie
Published: February 20, 2026

[18F]-FDG-PET/CT detects subclinical optic nerve inflammation in giant cell arteritis.

[18F]-FDG-PET/CT detects subclinical optic nerve inflammation in giant cell arteritis.

Journal: Frontiers in immunology
Published: February 03, 2026

Case Report: Switching secukinumab to bimekizumab in diffuse cutaneous systemic sclerosis after autologous hematopoietic stem cell transplantation: a case follow-up.

Case Report: Switching secukinumab to bimekizumab in diffuse cutaneous systemic sclerosis after autologous hematopoietic stem cell transplantation: a case follow-up.

Journal: Frontiers in immunology
Published: December 19, 2025

Joint Assessment Matters: Diagnostic and Therapeutic Benefits of Interdisciplinary Psoriasis Care.

Joint Assessment Matters: Diagnostic and Therapeutic Benefits of Interdisciplinary Psoriasis Care.

Journal: Advances in therapy
Published: December 11, 2025

An app-based nonpharmacological intervention improves patient-reported disease activity, functionality, and quality of life in patients with axial spondyloarthritis: a randomised controlled trial.

An app-based nonpharmacological intervention improves patient-reported disease activity, functionality, and quality of life in patients with axial spondyloarthritis: a randomised controlled trial.

Journal: Annals of the rheumatic diseases
Published: November 04, 2025
Showing 1-12 of 162

Last Updated: 09/26/2026